Five years ago, the US pharmaceutical company inaugurated its Yverdon production site. Its director, Bill Meury, today evokes its objectives of growth and diversification of its portfolio, in a context of American pressure and increasing competition from ChinaBased on Delaware, the US pharmaceutical company Incyte has been present in Switzerland for more than ten years. In 2020, it established its international headquarters in Morges for its act…
Five years ago, the US pharmaceutical company inaugurated its Yverdon production site. Its director, Bill Meury, today evokes its objectives of growth and diversification of its portfolio, in a context of American pressure and increasing competition from ChinaBased on Delaware, the US pharmaceutical company Incyte has been present in Switzerland for more than ten years. In 2020, it established its international headquarters in Morges for its act…